Rubius Therapeutics (RUBY) Earnings
|
Expand Research on RUBY
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -9.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/23/24 | Q423 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/20/23 | Q323 | N/A | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | N/A | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/23 | Q323 | N/A | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/27/23 | Q323 | N/A | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/28/23 | Q223 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/21/23 | Q223 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/15/23 | Q223 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A |
